Abstract
There are two instruments available for assessing a wide variety of non-motor symptoms (NMS) that may be present in Parkinson’s disease (PD). One is completed by the patient, and the other by the clinician. Once identified, some NMS may be assessed in more detail with specific scales, such as those described in Chapter 6.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
- Parkinson Disease
- Nonmotor Symptom
- Movement Disorder Society
- Clinimetric Property
- International Pilot Study
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21:916-923.
Martinez-Martin P, Schapira AHV, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord. 2007;22:1623-1629.
Cervantes-Arriaga A, Rodriguez-Violante M, Villar-Velarde A, Lopez-Gomez M, Corona T. [Metric properties of clinimetric indexes for non-motor dysfunction of Parkinson’s disease in Mexican population]. Rev Invest Clin. 2010;62:8-14.
Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Results from an international pilot study. Mov Disord. 2007;22:1901-1911.
Chaudhuri KR, Martinez-Martin P. Quantitation of non-motor symptoms in Parkinson’s disease. Eur J Neurol. 2008;15(suppl 2):2-7.
Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology. 2009;73:1584-1591.
Martinez-Martin P, Reddy P, Antonini A, et al. Chronic Subcutaneous Infusion Therapy with Apomorphine in advanced Parkinson’s disease compared to conventional therapy: a real life study of non motor effect. J Parkinsons Dis. 2011;1:197-203.
Reddy P, Martinez-Martin P, Rizos A, et al. Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects. Clin Neuropharmacol. 2012;35:205-207.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Healthcare
About this chapter
Cite this chapter
Martinez-Martin, P., Rodriguez-Blazquez, C., Forjaz, M.J., Chaudhuri, K.R. (2014). Comprehensive Non-motor Symptoms Assessments. In: Guide to Assessment Scales in Parkinson’s Disease. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-88-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-907673-88-7_5
Published:
Publisher Name: Springer Healthcare, Tarporley
Print ISBN: 978-1-907673-87-0
Online ISBN: 978-1-907673-88-7
eBook Packages: MedicineMedicine (R0)